NCT03726216 - Xydalba Utilization Registry in France | Biotech Hunter

Enrollment

151

Participants

Timeline

Start Date

September 6, 2018

Primary Completion Date

April 28, 2020

Study Completion Date

October 28, 2020

Conditions

Bacterial Infections

Interventions

DRUG

Xydalba

Information will be recorded about Xydalba administration (e.g. dose(s), number of infusions, length of infusions, dates or schedule of administration, sites of administration \[e.g. hospital, ICU\]), and reason for discontinuation, including response to treatment to assess whether the patient was clinically improving when Xydalba was discontinued

Trial Locations (15)

Unknown

Centre hospitalier d'Ajaccio, Maladies infectieuses et tropicales, Ajaccio

Centre Hospitalier Universitaire de Bordeaux, Hopital Saint-André, Bordeaux

CHU Bordeaux Pellegrin, Bordeaux

Hôpital Raymond-Poincaré, Garches

CHU GRENOBLE, Maladies infectieuses et tropicales, Grenoble

Hôpital de la Croix-Rousse, Service des maladies infectieuses et tropicales, Lyon

Centre Hospitalier de Mont de Marsan, Mont-de-Marsan

Centre hospitalier régional et universitaire de Nancy, Nancy

CHU de Nantes, Nantes

Centre hospitalier universitaire de Nice, Nice

Centre Hospitalier Universitaire de Nîmes (CHU), Nîmes

Hôpital Ambroise-Paré,Maladies infectieuses, Paris

Pontchaillou University Hospital, Infectious Diseases and Intensive Care Unit, Rennes

Centre hospitalier universitaire de Saint-Étienne, Saint-Etienne

Centre Hospitalier de Tourcoing,Service des Maladies Infectieuses et du Voyageur, Tourcoing